These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1499 related articles for article (PubMed ID: 19408160)

  • 1. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 108():2-32. PubMed ID: 19939209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
    Lacey CJ; Lowndes CM; Shah KV
    Vaccine; 2006 Aug; 24 Suppl 3():S3/35-41. PubMed ID: 16950016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HPV type in Recurrent Respiratory Papillomatosis.
    Donne AJ; Hampson L; Homer JJ; Hampson IN
    Int J Pediatr Otorhinolaryngol; 2010 Jan; 74(1):7-14. PubMed ID: 19800138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of human papillomaviruses (HPV) in benign and malignant tumors of the upper respiratory tract.
    Shen J; Tate JE; Crum CP; Goodman ML
    Mod Pathol; 1996 Jan; 9(1):15-20. PubMed ID: 8821950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of human papillomavirus types in anogenital warts of men.
    Chan PK; Luk AC; Luk TN; Lee KF; Cheung JL; Ho KM; Lo KK
    J Clin Virol; 2009 Feb; 44(2):111-4. PubMed ID: 19097933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.
    Komloš KF; Kocjan BJ; Košorok P; Luzar B; Meglič L; Potočnik M; Hočevar-Boltežar I; Gale N; Seme K; Poljak M
    J Med Virol; 2012 Aug; 84(8):1233-41. PubMed ID: 22711351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of human papilloma virus infections and genital neoplasia.
    Syrjänen K; Syrjänen S
    Scand J Infect Dis Suppl; 1990; 69():7-17. PubMed ID: 2175942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of mucosal human papillomavirus infection and associated diseases.
    Trottier H; Burchell AN
    Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.
    Ilboudo M; Zohoncon TM; Traore IMA; Traore EMA; Kande A; Obiri-Yeboah D; Djigma FW; Gyebre YMC; Simpore J
    Am J Otolaryngol; 2019; 40(3):368-371. PubMed ID: 30799210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification and assessment of multiple human papillomavirus types in condyloma acuminata lesions from patients with genital warts in Beijing area].
    Hong SL; Wang JB; Liu YH; Si JY; Xu XM; Guo XC; Zeng Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):397-400. PubMed ID: 12905662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections.
    Wiley DJ; Masongsong EV; Lu S; Heather L S; Salem B; Giuliano AR; Ault KA; Haupt RM; Brown DR
    Cancer Epidemiol; 2012 Jun; 36(3):e183-9. PubMed ID: 22277329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus types 6 and 11 seropositivity: risk factors and association with ano-genital warts among homosexual men.
    Poynten IM; Waterboer T; Jin F; Templeton DJ; Prestage G; Donovan B; Pawlita M; Fairley CK; Garland SM; Grulich AE
    J Infect; 2013 Jun; 66(6):503-11. PubMed ID: 23528181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
    Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
    Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.